STC and BioMelbourne Network, on behalf of the State Government of Victoria, are leading a major Medtech Mission to the United States in early October 2015,

We are currently seeking Expressions of Interest from Victorian medical technology companies, including medical devices, diagnostics and digital health, to participate in the Mission, which will include the AdvaMed 2015 Conference in San Diego, CA (4-7 October) with an additional itinerary in Minneapolis, MN one of the fastest growing medtech cities in the US (8-10 Oct).

The mission aims to support promising companies to make new B2B connections, engage with US medtech sector leaders and peak bodies, and grow market and investor readiness.

Who should go?
Companies with an interest in the US medical device sector looking for investment, strategic partnerships, licensing deals, service providers, business expansion, market entry and international networking opportunities. You will gain a deeper knowledge of the US MedTech market, insight into capital raising in the US and a greater understanding of partnering products and technologies with US companies. Experience the US medtech scene first hand and increase your connections, guided by the experienced mission leaders who will be on-hand to help you achieve your mission objectives.

BioMelbourne Network, STC Australia and the Victorian State Government will host a trade pavilion at the AdvaMed 2015 conference, and coordinate a comprehensive mission program of networking events, B2B meeting opportunities and site visits to meet the needs and interests of participating companies.

The value of the mission is our ability to facilitate introductions, create connections and opportunities to help you achieve your goals in the US.

AdvaMed 2015
AdvaMed 2015 is the leading MedTech focused conference in North America, bringing companies together in a uniquely multifaceted environment for business development, capital formation, innovative technology showcasing, world-class educational opportunities and networking.

AdvaMed is the US trade association that leads the effort to advance medical technology. AdvaMed represents 80% of the medical technology firms in the US.  It acts as the voice for companies producing medical devices, diagnostic and health information systems. AdvaMed organizes the premier conference for medical technology professionals, bringing together more than 1,000 companies in a uniquely multifaceted environment for educational opportunities, business development, capital formation, and networking. Attendees include: medtech company executives, policy makers, investors, and the media. AdvaMed 2014 attracted over 2,000 attendees including 287 international delegates from over 30 countries. For more information on the AdvaMed organization, please visit www.advamed.org

San Diego, CA 4 – 7 Oct. Host city for AdvaMed 2015.  The life sciences industry is a major driver of the innovation economy in the San Diego region. The region has more than 600 life science companies and more than 80 research institutes. The research institutes – along with the University of California, San Diego – provide the sector with breakthrough technologies that fuel company growth and product development. Major pharmaceutical companies including Pfizer, Johnson & Johnson and Merck maintain a presence in the region to foster collaboration with major research institutes, universities and smaller biotech companies.

Minneapolis, MN 8 – 10 Oct. Minnesota state boasts a local medtech sector second only in size to California and is home to global cardiology giant Medtronic.  Minneapolis hosts the major headquarters and facilities for industry leaders including 3M, Beckham Coulter and St Jude Medical.
US Medtech Mission Outcomes from 2014

The 2014 MedTech Mission to the US provided significant value to delegates by increasing their market awareness and connectivity in the US. The Mission successfully identified new business opportunities and investment leads for participating organisations as a direct result of meetings held during the Mission.

• Secured $33 million in new investment opportunities
• 36 firm business leads identified
• 4 participants secured significant new project deals or investments
• Ongoing relationships with investors, partners and clients arising from 2014 Mission.

100% of participants reported that involvement in the 2014 US Medtech Mission had a positive impact for their organisation by improving their commercial connectivity in the US.

Join us for US Medtech Mission 2015!

Cameron Boardman
Executive Director, Innovation,Technology & Industry Programs
Victorian Government

Buzz Palmer (STC Australia) and Dr Krystal Evans (BioMelbourne Network): Mission Leaders